R-Tech Ueno Overview
- Year Founded
-
1989
- Status
-
Acquired/Merged
- Employees
-
80
- Latest Deal Type
-
PIPE
- Latest Deal Amount
-
$10M
R-Tech Ueno General Information
Description
Developer of pharmaceuticals intended to develop solutions for unmet medical needs. The company is a Japanese pharmaceutical company that manufactures AMITIZA for Sucampo and Sucampo's commercialization partners, enabling its clients with research and development, manufacturing and marketing of drugs, development support, and contract manufacturing services.
Contact Information
Corporate Office
- NBF Hibiya Builing 10th Floor
- 1-1-7 Uchisaiwaicho Chiyoda-ku
- Tokyo, 100-0011
- Japan
Corporate Office
- NBF Hibiya Builing 10th Floor
- 1-1-7 Uchisaiwaicho Chiyoda-ku
- Tokyo, 100-0011
- Japan
R-Tech Ueno Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. PIPE | 22-Oct-2015 | $10M | 0000 | 000.00 | Completed | Profitable |
| 3. Merger/Acquisition | 13-Oct-2015 | 00000 | 00000 | Completed | Profitable | |
| 2. IPO | 01-Mar-2008 | Completed | Profitable | |||
| 1. Early Stage VC | Completed | Profitable |
R-Tech Ueno Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
R-Tech Ueno Patents
R-Tech Ueno Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20170020890-A1 | Pharmaceutical composition comprising fatty acid derivative | Inactive | 19-Jun-2015 | 0000000000 | |
| JP-2018076236-A | Pharmaceutical composition for treating cancer | Pending | 05-Jun-2015 | 0000000000 | |
| JP-2018080114-A | Anti-human vap-1 monoclonal antibody | Pending | 29-May-2015 | 000000000 | |
| JP-2016222563-A | Ophthalmological composition for treating pigmentary degeneration of retina | Pending | 28-May-2015 | ||
| JP-2018080113-A | Treatment agent of cerebral infarction | Pending | 27-May-2015 | A61K31/496 |
R-Tech Ueno Executive Team (4)
| Name | Title | Board Seat |
|---|---|---|
| Ryuji Ueno Ph.D | Co-Founder |
R-Tech Ueno Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
R-Tech Ueno Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Nissay Capital | Venture Capital | Minority | 000 0000 | 000000 0 |
R-Tech Ueno FAQs
-
When was R-Tech Ueno founded?
R-Tech Ueno was founded in 1989.
-
Who is the founder of R-Tech Ueno?
Sachiko Kuno Ph.D and Ryuji Ueno Ph.D are the founders of R-Tech Ueno.
-
Where is R-Tech Ueno headquartered?
R-Tech Ueno is headquartered in Tokyo, Japan.
-
What is the size of R-Tech Ueno?
R-Tech Ueno has 80 total employees.
-
What industry is R-Tech Ueno in?
R-Tech Ueno’s primary industry is Drug Delivery.
-
Is R-Tech Ueno a private or public company?
R-Tech Ueno is a Private company.
-
What is the current valuation of R-Tech Ueno?
The current valuation of R-Tech Ueno is 000.00.
-
What is R-Tech Ueno’s current revenue?
The current revenue for R-Tech Ueno is 000000.
-
How much funding has R-Tech Ueno raised over time?
R-Tech Ueno has raised $10M.
-
Who are R-Tech Ueno’s investors?
Nissay Capital has invested in R-Tech Ueno.
-
When was R-Tech Ueno acquired?
R-Tech Ueno was acquired on 22-Oct-2015.
-
Who acquired R-Tech Ueno?
R-Tech Ueno was acquired by Sucampo Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
